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randomized trials while a certain practice at vahanco with con¢lus~,ns from 
meanm~,e~ trials may I~ explained by more optimal conventional PTCA 
made possible by the stent option, 
St tnt  Uae In Internal Mammary  Graft Angloplasty 
- A 4 -YRr  Exper ien~ 
M, T~be~, M, Mimlo~, G, Plud~, R, M~hr~n, E, Pinnaw, S, ~l~ke~r, 
1", O~¢l~r, J. Popma, A. P~'~,d, J, Um~Ls~y, Jr. I/V~t~ngt~ H~/~f~t 
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routir~, in r~t  catt'~t~zat~n ~ent~r~, ~um~n~t J~ ~ eff~cy 
el st~t~ in IMA ~I t  ~t~ ~s  ~ been reported, 
M#/t I~:  IMA 9r~Jft OP ,~)~i~/~ p~oet11~ in 145 I~t~ t O~r it~tit~r~on 
between Ja~l~ly leg4 ~ M, W 1997, StifflY, ~m d~k~yed il~ ~ (19,~;~,), 
Of I~11~ M~I{~/ .  I~ l Jon  fg~ Ment I ~ t  W~S r~0l ~mnt  !n 
B I~l, L~mn Io¢~ti(m wltt~n the IMA w~ ~n in i t§  ply. Only 10 (36%) 
w~m ~ in an ~ site ~ ~ ~ ~teno~ ~'c~nled 
I~ ?'~'~ Of Oft tr~te¢l e~s .  Hm~p~r, mean age ~ lha ~ratl in the two 
P ~  w~s sm'~Tar I~te  and L~t~,n  o~t~ (6 month~ to 3 
years) m ~ pts ~ ehown be~k~w. No stem pt ~e~, ~ ~ut ,  mwcardia~ 
(nf~ct,~n Ot emer~nt CA~3 ~ tO the PmCt~m. The ;2 d~Wm m 
Merit ~ o¢~lmd within (;me ~ from t)~ l~x:e(k~re. Both had ~vere 
~oa~t  d~s~ase. One was in CardiogeniC ShOCk end ~ red~ GABG 
week I~tm. 
No-stenr 89 82 8 i o 275 4 (3.9%) 
Stem 24 964 7 4 i ~aS 2 (9.5%) 
Conct~ Slant use m IMA graft a ,~ las ty  in prol~dy self'ted pts is 
safe ar~ efficacious. 
• F~¢~.C~IUtal Results and Late Clinical Outcomes 
Fol lowing Mult ivessel  Coronary  Slentin 9 
R KOmowski, LF. Salter,/LD. Pichard, KM. KenL MK. l-kmo R. Mehran, 
JJ. Pot:~na, J.R Laird, M.B, Lemn. Washington Hospt~ Center, DC. JSA 
Back~m~,ed: Conventional PTCA m muttme, ssel coronary disease has been 
limited by higher rate el restenosis and recunent angina compared to single- 
vessel coronary interventions. 
Methods: We evaluated procedural success, major ln+hoSl:ntal compli- 
C~bons, repeat revascularization and ctin~c~l outcomes @ (1 ye~) in 2,377 
consecutive patients (3,552 nat~vecomnaty lesions) who underwent one-t/me 
procedure of multJvessal (94% with Iwo vessels stenfmg) vs. sir~Pvessel 
stenting. Repeat revasculafization is reporled @ 1 year per.patient and im 
dudes all target lesion and target veSsel revaScularizatlons for single and 
multiple vessel disease. 
Results: (Tatge) 
# ~essels (# Patients) S~ng/e (r958) MuJr~ (~rg) P 
Procedure success (%) 97 t 962 036 
Hospital death/Ml/CAJ~G (%) 0.610.7/I 6 05/O 9/05 0 31(0.65/0.08 
Repeat mva.scu~mza~on (%) 200 21 6 056 
Deatll~11 ( yr) (%) 1 5/1 3 07(0 020/002 
Event-free survival (1 yr) (%) 759 779 0.81 
Cot~clusions: Unlike previous PTCA experier~'es, mull~vesseI coronary 
startling does not confer incremental procedural complications or repeat 
revaSculahzation dsk compared with single vessel treatment. Thus, slant- 
ing may be the preferred therapeutic strategy in patients with multivessel 
coronary disease. 
~ R i s k  for  Procedural Fai lure at  Coronary Stent 
Placement 
H. SchQhlen, A. Kastrati, J. Hausieiter, S. Elezi, J. Dirschinger, A. $chbmig. 
DeutsChes Herzzentrum & Klinikum rechts der Isar, Technische UniversitdL 
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Background: The utilization of coronary stents has been growing continu- 
ously with broadening indications, Although stent placement is technically 
more difficult than stander~ PTCA, it may be achieved with high success 
rates, However, a comDml~ens=ve ~t'~lyst~,  tt~ n~ of IX¢~J~r~l t~e ~' 
assom~t~l aff~ePse ven~ is r~t eV~l~L~e, 
Me~Od~; W~ analyzed all ~B94 ~l~ntmg ~'o¢~'~u~ mtl~ k~t ~ ye-~r~ 
I~d0nlle~ at Our in~tit~to~ (~,l~',e ha~ted  ~(~t~ ~,1(~t'ff~) 
Re~.~/t~ Pr0¢~dural ~e,¢ce~ (l~tcem~nt al tMg64 ipo~tkott wtlh =30% 
myo~l  in f~t~ (MI), 14,8 vs, 2,0% (OR 1~,4~ Ct, 3,~=1tL3), ~1~,  MI 
t~ I~tt; t~  moet ~g~ir~nt t~o~ w~ tl~ i ~  ~ m ~r~ 
r~m~t  t~t~l~e~ t5 ~d~t io~ facto~ w~l  into me ~ w~ not 
~ed in ~c~ MI. 
~temottl~ grime -~-  
~lllnllng 
~1 1 10 
Con¢lu~on~: The rote of IprOcR~#-~ spCCeS~ iS high,/),tier f~dure I I~ ,  
undersc~e, ~ need lo~ ol~miza~on of techncal eq~t  as well em 
ot~mti~lal skifl~. 
• Comnsry 5~n~ng With Different Indic~Uons 
Y K~td ,  M. Far.re, B, Rmmers, T, AkqFama, J. de Gregorm, C. Di 
Made, G. M3rttni, L D( Francesca, L. Rnej, A. CO~ Centre C~om 
Columbus, M~tano, tta~ 
The I~tpose ol Ibis Study was to (teteml~ie medium-ffirm ~(n~l  ~ 8n- 
g,,ographic results m patients having ¢oronarf slant deployment for venous 
[lldicatig~ TI~ literature sllows dNer$~ results with different C l~ l  in, 
dicatLons. We analy~e~ t~s re.~tS Of Cor0r~ry Stent in'tptanlat~n for the 
following indications: elective therapy, for restenosis after at~JmplaSly (Rest), 
for a subop~mal result after angioplasty (Sul~opt R), tar acute or th re~t~ 
vessel closure (A&TC), and after successful recanahzatlon of a cfltontc lolal 
ecctuston (CTO). The inbavaScutar ultrasound and h~gh pressure final hal. 
Loon inflations were used in rnajonty ut cases. Clinu~l foll~e,~-up was avaLlable 
at 22 -,~ 16 menlhs 
R~sult~: 
Im:EcaPm~: ~¢¢t=ve Rest Subop! R A&TC (3'TO 
#pLs 1026 205 232 tB1 262 
Success % 99 96 9*3 93 96 
Mulup/e ste~ts 31% 2B% 36% 5;~%" 5~,b" 
Sten! p~" patient t 7 1 5 1 b 3,2" 20 
Con~ptCa~ms 5% 6% 7% t 8%" 6% 
SST 1 8% 1.7% 1.4% 1.1% t% 
Restenot~s 25% 28% ~5% 37%" 33,%" 
TLR 16% 16,% 18% 2D% 21% 
MACE 35% 31% 38% 50~ -* 38% 
• p .~ a 0t O0mp To tt,e letuP.st value; SST = sub,cute sTent hrofftbos~s 
Conclusions: The ,,se of coronary stents is safe and yields similar acute 
results with different indications, except for the A&TC The restenasis rate 
remains the major problem, in particular when stents are implanted for acute 
ar thmaterm¢l closure or following reopening a CTO. At two years MACE 
occurred tn in more than 1/3 of the patients independently of the stent 
indication. 
• R i s k  Factor Analysis for Stent Occlusion Within the First Month After Successful Coronary Stent 
Placement 
A. Sch~mig, A. Kastmti, H. ,SCh~hlen, S. Elezi, J. Hausleiter, J. DirSchinger. 
Med. Klinik & Deutsches HerzZentrum, TU MEmc#en, Germany 
Background: Technical refinements and improvements in the post-procedural 
antithmmbotic regimen have reduced the rate at st~nt occlusion (OCCL). 
Still, the rate of OCCL may vary substantially, depending on differences in 
patient and lesion characteristics, We analyzed the risk of OCCL for all 2833 
successful stenting procedures performed within the laSt 5 years, 
